NFlection Therapeutics

Boston, MA · Founded 2014 · Privately Held (backing)

Developer of topical therapies designed to address rare skin disorders associated with abnormal RAS pathway activity. NFlection Therapeutics is based in Boston, MA and was founded in 2014. It was valued at $156 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $65.5 million across 3 recorded rounds; the latest was a $4 million seed round in Jul 2023.

PMV mark · valuation
$156.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$65.5M
Last round
Seed Round
Jul 2023
What is NFlection Therapeutics worth?
$156.0MPrivateMarketView mark · Oct 2026

Valued at $156.0M at its later-stage round, Aug 2025. Nothing has traded since.

Free account
More of NFlection Therapeutics with a free account
  • ·Watch NFlection Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

NFlection Therapeutics funding history

3 rounds
DateRoundRaisedPost-money
Jul 2023Seed Round$4.0M▮
Jun 2022Early Stage VC$20.0M▮
Dec 2016Seed Round$1.4M▮
Unlock post-money valuations

Membership and data by Private Market View

NFlection Therapeutics valuation

NFlection Therapeutics was valued at $156 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has NFlection Therapeutics raised?

NFlection Therapeutics has raised $65.5 million in total; 3 of its rounds are on record, from 2016 on. The largest on record was a $4 million seed round in Jul 2023.

NFlection Therapeutics has filed 4 Form Ds with the SEC since 2017, most recently in Jul 2023 ($4 million sold to 2 investors).

How NFlection Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For NFlection Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about NFlection Therapeutics

What is NFlection Therapeutics worth?
NFlection Therapeutics is valued at $156.0M as of Oct 2026. Valued at $156.0M at its later-stage round, Aug 2025. Nothing has traded since.
How much has NFlection Therapeutics raised?
NFlection Therapeutics has raised $65.5M in total funding across 3 recorded rounds.
When did NFlection Therapeutics last raise?
NFlection Therapeutics last raised in Jul 2023 (Seed Round), raising $4.0M.